SCHEMBL6363949

SCHEMBL6363949

CC(=O)Oc1c(I)cc(I)c(I)c1OC(C)=O

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.43
▸ NLRP3 Q96P20 1/20 0.43
▸ TOP1 P11387 3/20 0.39
▸ CYP3A4 P08684 1/20 0.37
▸ BACE1 P56817 1/20 0.37
▸ HTT P42858 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ TPMT P51580 2/20 0.35
▸ PREP P48147 3/20 0.35
▸ CELA1 Q9UNI1 2/20 0.35
▸ ABCB11 O95342 1/20 0.35
▸ MAPK1 P28482 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ KDR P35968 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27426714 0.80 MCL1 (0.41) POLBNLRP3TOP1CYP3A4BACE1
SCHEMBL22991606 0.80 POLB (0.39) POLBNLRP3TOP1CYP3A4BACE1
SCHEMBL22991542 0.78 POLB (0.35) POLBNLRP3TOP1CYP3A4BACE1
SCHEMBL14136180 0.77 LMNA (0.43) POLBNLRP3TOP1BACE1HTT
SCHEMBL24110787 0.76 TPMT (0.47) POLBNLRP3CYP3A4BACE1HTT
SCHEMBL22991508 0.76 POLB (0.36) POLBNLRP3TOP1CYP3A4BACE1
SCHEMBL22991509 0.75 POLB (0.38) POLBNLRP3TOP1BACE1HTT
SCHEMBL24106114 0.75 ABCB11 (0.37) POLBNLRP3BACE1GAAMAPT
SCHEMBL24106257 0.74 ABCB11 (0.43) POLBNLRP3TOP1CYP3A4BACE1
SCHEMBL22991506 0.74 POLB (0.35) POLBNLRP3TOP1BACE1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050010019-A1 Diaminodicarboxylic acids and intermediates thereof MITSUI CHEMICALS, INC. (JP) 2005-01-13 — — US disclosed
EP-1460058-A1 DIAMINODICARBOXYLIC ACIDS AND INTERMEDIATES THEREOF Mitsui Chemicals, Inc. (JP) 2004-09-22 — — EP disclosed
EP-0828704-B1 METHODS OF MAKING (S)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID WARNER LAMBERT CO (US) 2002-03-13 — — EP disclosed
US-5629447-A Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid WARNER-LAMBERT COMPANY (US) 1997-05-13 — — US disclosed
US-5616793-A Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid WARNER-LAMBERT COMPANY (US) 1997-04-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050010019-A1 Diaminodicarboxylic acids and intermediates thereof DDC, ODC1, ASS1 POLB 2910/4885NLRP3 2285/4885TOP1 4574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback